Regulation of gene expression by the CYP27B1 promoter - study of a transgenic mouse model

被引:20
|
作者
Hendrix, I [1 ]
Anderson, P
May, B
Morris, H
机构
[1] Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Sch Mol & Med Biosci, Adelaide, SA 5005, Australia
来源
关键词
vitamin D; 25-hydroxyvitamin D 1-hydroxylase; transgene;
D O I
10.1016/j.jsbmb.2004.03.093
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme 25-hydroxyvitamin D I-hydroxylase(CYP27B1) is the rate limiting enzyme in the two-step activation process of Vitamin D to its active form 1,25-dihydroxyvitamin D (1,25D) and is located in the mitochondrial fraction of the proximal tubular cells of the kidney. More recently CYP27B1 activity and expression have also been identified in a number of non-renal cells, which is suggestive of new, previously unidentified roles for Vitamin D in the human body. Although the regulation of CYP27B1 activity and expression has been a major focus of interest over the past decades, the exact molecular mechanism behind the regulation of CYP27B1 activity and expression and the role of the CYP27B1 promoter, herein, are still poorly understood. In this study, we created a transgenic mouse model that expresses the luciferase reporter gene under the control of the full-length, 1.5 kb, human CYP27B1 promoter. This animal model allows us to study in vivo the tissue-specific, CYP27B1 promoter-controlled, regulation of the expression of the CYP27B1 gene. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [1] Co-expression of CYP27B1 enzyme with the 1.5 kb CYP27B1 promoter-luciferase transgene in the mouse
    Anderson, Paul H.
    Hendrix, Ivanka
    Sawyer, Rebecca K.
    Zarrinkalam, Reza
    Manavis, Jim
    Sarvestani, Ghafar T.
    May, Brian K.
    Morris, Howard A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 285 (1-2) : 1 - 9
  • [2] Interaction between mitochondrial CYP27B1 and adrenodoxin: Role of arginine 458 of mouse CYP27B1
    Urushino, N
    Yamamoto, K
    Kagawa, N
    Ikushiro, S
    Kamakura, M
    Yamada, S
    Kato, S
    Inouye, K
    Sakaki, T
    BIOCHEMISTRY, 2006, 45 (14) : 4405 - 4412
  • [3] Regulation of CYP27B1 mRNA Expression in Primary Human Osteoblasts
    K. van der Meijden
    H. W. van Essen
    F. W. Bloemers
    E. A. J. M. Schulten
    P. Lips
    N. Bravenboer
    Calcified Tissue International, 2016, 99 : 164 - 173
  • [4] Regulation of CYP27B1 mRNA Expression in Primary Human Osteoblasts
    van der Meijden, K.
    van Essen, H. W.
    Bloemers, F. W.
    Schulten, E. A. J. M.
    Lips, P.
    Bravenboer, N.
    CALCIFIED TISSUE INTERNATIONAL, 2016, 99 (02) : 164 - 173
  • [5] INCREASED BONE VOLUME IN THE BONE-SPECIFIC CYP27B1 TRANSGENIC MOUSE
    Turner, A. G.
    O'loughlin, P. D.
    Kogawa, M.
    Atkins, G. J.
    Anderson, P. H.
    Morris, H. A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S590 - S591
  • [6] Increased trabecular volume in the bone-specific CYP27B1 transgenic mouse
    Morris, H. A.
    Turner, A. G.
    Sawyer, R. K.
    O'Loughlin, P. D.
    Anderson, P. H.
    BONE, 2011, 48 : S78 - S78
  • [7] Relationship between gene promoter polymorphism of cyp27b1 and susceptibility to ulcerative colitis
    Zhu, F-L
    Zhang, G-Z
    Han, J-S
    Liu, L.
    Zhang, X-L
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 117 - 117
  • [8] Derepression of CYP27B1 gene expression mediates DNA-demethylation
    Kim, M.
    Takada, I.
    Takeyama, K.
    Kato, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S182 - S182
  • [9] Regulation of the 5′-flanking region of the human CYP27B1 gene in osteoblast cells
    Turner, A. G.
    Dwivedi, P. P.
    Anderson, P. H.
    May, B. K.
    Morris, H. A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 311 (1-2) : 55 - 61
  • [10] Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues
    Zhalehjoo, Naghmeh
    Shakiba, Yadollah
    Panjehpour, Mojtaba
    MOLECULAR MEDICINE REPORTS, 2017, 15 (01) : 467 - 473